BIO-TECHNE Corp Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
BIO-TECHNE Corp (TECH) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $18.44 million for the 12-month period ending 2025-06-30, per its 10-K filed 2025-08-22.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2025-08-22
- BIO-TECHNE Corp other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-06-30 was -$3.01M, a 140.19% decline year-over-year.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-03-31 was -$11.65M, a 839.90% decline year-over-year.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-12-31 was $14.36M, a 13.96% decline year-over-year.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-09-30 was -$11.95M.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $18.44M.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$12.25M, a 234.11% decline from fiscal 2023.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $9.14M.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$17.91M, a 144.88% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-06-30 | $18.44M 10-K · filed 2025-08-22 | |||
| 2024-06-30 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | -$14.65M derived: sum of 2 quarters · filed 2025-08-22 | -$300.00K derived: sum of 3 quarters · filed 2025-08-22 | -$12.25M 10-K · filed 2025-08-22 |
| 2024-03-31 | -$11.65M 10-Q · filed 2024-05-06 | $2.71M derived: sum of 2 quarters · filed 2024-05-06 | -$9.24M 10-Q · filed 2024-05-06 | -$1.76M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-12-31 | $14.36M 10-Q · filed 2024-02-07 | $2.40M 10-Q · filed 2024-02-07 | $9.89M derived: sum of 3 quarters · filed 2025-08-22 | $11.46M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-09-30 | -$11.95M 10-Q · filed 2023-11-07 | -$4.46M derived: sum of 2 quarters · filed 2025-08-22 | -$2.89M derived: sum of 3 quarters · filed 2025-08-22 | $13.79M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-06-30 | $7.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $9.06M derived: sum of 2 quarters · filed 2025-08-22 | $25.75M derived: sum of 3 quarters · filed 2025-08-22 | $9.14M 10-K · filed 2025-08-22 |
| 2023-03-31 | $1.57M 10-Q · filed 2024-05-06 | $18.26M derived: sum of 2 quarters · filed 2024-05-06 | $1.65M 10-Q · filed 2024-05-06 | -$18.41M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-12-31 | $16.68M 10-Q · filed 2024-02-07 | $75.00K 10-Q · filed 2024-02-07 | -$19.98M derived: sum of 3 quarters · filed 2024-08-22 | -$15.65M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-09-30 | -$16.61M 10-Q · filed 2023-11-07 | -$36.66M derived: sum of 2 quarters · filed 2024-08-22 | -$32.34M derived: sum of 3 quarters · filed 2024-08-22 | -$27.59M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-06-30 | -$20.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | -$15.73M derived: sum of 2 quarters · filed 2024-08-22 | -$10.98M derived: sum of 3 quarters · filed 2024-08-22 | -$17.91M 10-K · filed 2024-08-22 |
| 2022-03-31 | $4.33M 10-Q · filed 2023-05-08 | $9.07M derived: sum of 2 quarters · filed 2023-05-08 | $2.15M 10-Q · filed 2023-05-08 | $8.88M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-12-31 | $4.74M 10-Q · filed 2023-02-07 | -$2.18M 10-Q · filed 2023-02-07 | $4.55M derived: sum of 3 quarters · filed 2023-08-23 | $4.76M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-09-30 | -$6.92M 10-Q · filed 2022-11-07 | -$193.00K derived: sum of 2 quarters · filed 2023-08-23 | $22.00K derived: sum of 3 quarters · filed 2023-08-23 | $18.93M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-06-30 | $6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $6.95M derived: sum of 2 quarters · filed 2023-08-23 | $25.85M derived: sum of 3 quarters · filed 2023-08-23 | $39.91M 10-K · filed 2023-08-23 |
| 2021-03-31 | $215.00K 10-Q · filed 2022-05-09 | $19.12M derived: sum of 2 quarters · filed 2022-05-09 | $33.18M 10-Q · filed 2022-05-09 | $39.43M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-12-31 | $18.90M 10-Q · filed 2022-02-07 | $32.96M 10-Q · filed 2022-02-07 | $39.22M derived: sum of 3 quarters · filed 2022-08-24 | $14.11M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-09-30 | $14.06M 10-Q · filed 2021-11-08 | $20.32M derived: sum of 2 quarters · filed 2022-08-24 | -$4.79M derived: sum of 3 quarters · filed 2022-08-24 | $8.48M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-06-30 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | -$18.85M derived: sum of 2 quarters · filed 2022-08-24 | -$5.57M derived: sum of 3 quarters · filed 2022-08-24 | -$13.68M 10-K · filed 2022-08-24 |
| 2020-03-31 | -$25.11M 10-Q · filed 2021-05-07 | -$11.83M derived: sum of 2 quarters · filed 2021-05-07 | -$19.94M 10-Q · filed 2021-05-07 | -$23.82M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-12-31 | $13.28M 10-Q · filed 2021-05-07 | $5.17M 10-Q · filed 2021-02-08 | $1.28M derived: sum of 3 quarters · filed 2021-08-25 | $4.66M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-09-30 | -$8.11M 10-Q · filed 2021-05-07 | -$11.99M derived: sum of 2 quarters · filed 2021-08-25 | -$8.62M derived: sum of 3 quarters · filed 2021-08-25 | -$20.99M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-06-30 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | -$509.00K derived: sum of 2 quarters · filed 2021-08-25 | -$12.89M derived: sum of 3 quarters · filed 2021-08-25 | -$14.02M 10-K · filed 2021-08-25 |
| 2019-03-31 | $3.38M 10-Q · filed 2020-05-11 | -$9.00M derived: sum of 2 quarters · filed 2020-05-11 | -$10.14M 10-Q · filed 2020-05-11 | -$39.09M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-12-31 | -$12.38M 10-Q · filed 2020-05-11 | -$13.52M 10-Q · filed 2020-02-06 | -$42.47M derived: sum of 3 quarters · filed 2020-08-26 | -$1.51M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-09-30 | -$1.14M 10-Q · filed 2020-05-11 | -$30.09M derived: sum of 2 quarters · filed 2020-08-26 | $10.87M derived: sum of 3 quarters · filed 2020-08-26 | $3.81M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-06-30 | -$28.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $12.00M derived: sum of 2 quarters · filed 2020-08-26 | $4.95M derived: sum of 3 quarters · filed 2020-08-26 | $4.12M 10-K · filed 2020-08-26 |
| 2018-03-31 | $40.96M 10-Q · filed 2019-05-07 | $33.90M derived: sum of 2 quarters · filed 2019-05-07 | $33.07M 10-Q · filed 2019-05-07 | $49.43M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-12-31 | -$7.06M 10-Q · filed 2019-05-07 | -$7.88M 10-Q · filed 2019-02-07 | $8.48M derived: sum of 3 quarters · filed 2019-11-06 | $10.40M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-09-30 | -$824.00K 10-Q · filed 2019-05-07 | $15.54M derived: sum of 2 quarters · filed 2019-11-06 | $17.46M derived: sum of 3 quarters · filed 2019-11-06 | $14.17M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-06-30 | $16.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $18.28M derived: sum of 2 quarters · filed 2019-11-06 | $15.00M derived: sum of 3 quarters · filed 2019-11-06 | $21.47M 10-K/A · filed 2019-11-06 |
| 2017-03-31 | $1.93M 10-Q · filed 2018-05-09 | -$1.36M derived: sum of 2 quarters · filed 2018-05-09 | $5.11M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | -$3.29M 10-Q · filed 2018-02-08 | $3.19M 10-Q · filed 2018-02-08 | ||
| 2016-09-30 | $6.48M 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$39.81M 10-K · filed 2018-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |